A multicenter, randomized, double-blind, placebo controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder

Trial Profile

A multicenter, randomized, double-blind, placebo controlled study of aripiprazole monotherapy in the treatment of acutely manic patients with bipolar I disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Aripiprazole (Primary) ; Haloperidol
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical Development & Commercialization
  • Most Recent Events

    • 01 Jan 2009 Results have been published in the British Journal of Psychiatry.
    • 03 May 2008 Results have been presented at the 161st Annual Meeting of the American Psychiatric Association.
    • 31 Jul 2007 Status change from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top